Search

everythinglearnresearchcommunity

for

Search:↓

Many skin patients also have mental health issues, and doctors should treat both together.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Finasteride can cause sexual problems and depression in young men.

Using skin stem cells and certain molecules might lead to scar-free skin healing.

Cocaine impairs male sexual behavior and alters testosterone metabolism in the brain.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

European dermatologic treatments focus on lifestyle and psychosocial factors, use diverse methods like baths and climate therapy, and emphasize the importance of diet and supplements for skin health.

Silk sericin dressing with collagen heals wounds faster and improves scar quality better than Bactigras.

Some cosmetics and dermatological drugs can cause allergic reactions and side effects, like skin irritation and systemic issues.

Microneedle technology has advanced for painless drug delivery and sensitive detection but faces a gap between experimental use and clinical needs.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Natural skincare products may help reduce sun damage and support the skin's daily cycle.

Long-term opioid use can cause a serious condition where the adrenal glands don't work properly, which doctors should watch out for.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Many medications can cause hair loss or excessive hair growth, which is usually reversible after stopping the drug.

Finasteride may help reduce opioid use.

NSAIDs may not affect soft tissue healing but should be used carefully for bone fractures and more research is needed to understand sex differences in response.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Human skin cells produce proenkephalin, which changes with environmental factors and skin diseases.

Both a lock of hair and a single hair strand can show chronic drug use, but at least six single hairs are needed for accurate results.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Serum triglyceride levels are not linked to prostate cancer risk.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.